Secretive Seattle Biotech Company Raises More Than $700M To Develop New Ways To Modify Genes

by geekwire.com posted 8months ago 40 views
Sana Biotechnology today formally announced that it has raised more than $700 million in venture funding — one of the largest venture financing deals in the life sciences industry and one of the biggest rounds on record in Seattle. “Sana is dedicated to modulating genes in cells as well as replacing damaged cells in the body,” Sana CEO Steve Harr said in a press release.

In this article